These findings suggested that GTSE1 silencing inhibits the proliferation and invasion of HCC cells may be mediated by affecting the phosphorylation level of AKT and the expression of BCL-2, Bax, and cyclin B1. Here, AKT1 is linked to hepatocellular carcinoma.